PATENT CLAIM ANALYSIS

Application Number: 16090317
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-04
Patent Classification: ["514", "161000"]

Abstract:
Methods of treating and preventing conditions of a nasal or paranasal mucous membrane are described. The methods include administering a pharmaceutical composition including a nicotinic acetylcholine receptor (nAChR) agonist, such as (S)-(1-methyl-2-pyrrolidinyl)-pyridine, or a pharmaceutically acceptable salt, analog, precursor or derivative thereof. The methods can be used to treat a wide variety of conditions of the nasal or paranasal mucous membrane, such as nasal congestion and nose bleeds.

Claim (Index 8):
The method of  claim 1 , wherein the pharmaceutical composition is an aqueous solution.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 97.0
- Lexical Diversity: 1.57407
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14470197', '12675257', '15004807', '10912578', '13838959']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7897674331837335
- 35 USC 102 Novelty (BERT): 0.5118481877400315
- Combined Prediction Score: 0.7619755086393634
- Mean Citation Score: 236.049792
- Max Citation Score: 266.14062
- Similarity Product: 169.40772141295554

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test